Novel dengue serotype 4 live virus human challenge: a phase 1 dose optimisation and homologous rechallenge study. // The Lancet Microbe. – URL: https://www.sciencedirect.com/science/article/pii/S2666524726001977?dgcid=rss_sd_all
Novel dengue serotype 4 live virus human challenge: a phase 1 dose optimisation and homologous rechallenge study. The Lancet Microbe. https://www.sciencedirect.com/science/article/pii/S2666524726001977?dgcid=rss_sd_all
“Novel dengue serotype 4 live virus human challenge: a phase 1 dose optimisation and homologous rechallenge study.” The Lancet Microbe.
@article{article68923,
title = {Novel dengue serotype 4 live virus human challenge: a phase 1 dose optimisation and homologous rechallenge study},
journal = {The Lancet Microbe},
url = {https://www.sciencedirect.com/science/article/pii/S2666524726001977?dgcid=rss_sd_all}
}